Armistice Capital, LLC 13D and 13G filings for ProMIS Neurosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 9:36 pm Purchase | 2025-12-31 | 13G | PROMIS NEUROSCIENCES INC PMN | Armistice Capital, LLC | 504,673 0.930% | 385,692 (+324.16%) | Filing |
| 2025-11-14 6:26 pm Sale | 2025-09-30 | 13G | PROMIS NEUROSCIENCES INC PMN | Armistice Capital, LLC | 118,981 5.530% | -73,499 (-38.19%) | Filing |
| 2025-08-15 12:28 pm Purchase | 2025-06-30 | 13G | PROMIS NEUROSCIENCES INC PMN | Armistice Capital, LLC | 192,480 8.580% | 99,087 (+106.10%) | Filing |
| 2025-05-15 3:37 pm Sale | 2025-03-31 | 13G | PROMIS NEUROSCIENCES INC PMN | Armistice Capital, LLC | 93,393 7.140% | -7,006 (-6.98%) | Filing |
| 2025-02-14 5:17 pm Sale | 2024-12-31 | 13G | PROMIS NEUROSCIENCES INC PMN | Armistice Capital, LLC | 100,399 7.680% | -6,401 (-5.99%) | Filing |
| 2024-11-14 3:36 pm Purchase | 2024-09-30 | 13G | PROMIS NEUROSCIENCES INC PMN | Armistice Capital, LLC | 106,800 8.170% | 106,800 (New Position) | Filing |